Medical marijuana is known to have helped with many health issues and has even worked better than conventional medicines in some cases. Both Cambridge, U.K.-based GW Pharmaceuticals (NASDAQ: GWPH) and Massachusetts, U.S.-based Corbus Pharmaceuticals Holdings' (NASDAQ: CRBP) stocks are up double-digits to 29.4% and 27.2% year to date, while the market is down by 0.66% as tracked by the SPDR S&P 500 ETF. GW Pharmaceuticals has been seeing staggering revenue growth this year, and it appears it could further surge thanks to the rising sales of Epidiolex. Read More...
Better Buy: GW Pharmaceuticals vs. Corbus Pharmaceuticals
Medical marijuana is known to have helped with many health issues and has even worked better than conventional medicines in some cases. Both Cambridge, U.K.-based GW Pharmaceuticals (NASDAQ: GWPH) and Massachusetts, U.S.-based Corbus Pharmaceuticals Holdings’ (NASDAQ: CRBP) stocks are up double-digits to 29.4% and 27.2% year to date, while the market is down by 0.66% as tracked by the SPDR S&P 500 ETF. GW Pharmaceuticals has been seeing staggering revenue growth this year, and it appears it could further surge thanks to the rising sales of Epidiolex.
Add Comment